Literature DB >> 20188224

Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation.

Kriangsak Songsrirote1, Zhi Li, David Ashford, Andrew Bateman, Jane Thomas-Oates.   

Abstract

PGRN is a modular protein with 7 1/2 repeats of the granulin domain separated by short spacer sequences. Elevated expression of PGRN is associated with cancer growth, while mutations of PGRN cause frontotemporal lobar degeneration (FTLD), an early onset form of dementia. PGRN is a glycoprotein, containing five N-glycosylation consensus sequons, three of which fall within granulin domains. A method tailored to enable detailed analysis of the PGRN oligosaccharides and glycopeptides has been developed. The approach involves in-gel deglycosylation using peptide-N-glycosidase F (PNGase F) followed by permethylation of the released oligosaccharides. Permethylation was applied for rapid sample clean-up and to improve sensitivity of MS detection and mass spectrometric fragmentation. Reversed-phase monolithic LC-ESI-MS/MS was used for analysis of permethylated oligosaccharides, enabling structural characterization of released N-linked glycans in one chromatographic run. In-gel tryptic digestion was further applied to the gel pieces containing deglycosylated protein, for N-glycosylation site determination. In addition, glycopeptides were produced using in-solution pronase digestion to identify species of N-glycan attached at particular sites. The method developed was applied to progranulin (PGRN) to characterize the structures of the released glycans and to identify the sites of glycosylation. Glycosylation of four out of five potential PGRN N-glycosylation consensus sites was demonstrated (the final one remains undetermined), with one of the four observed to be partially occupied. Two of the observed glycosylation sites occur within granulin domains, which may have important implications for understanding the structural basis of PGRN action. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188224     DOI: 10.1016/j.jprot.2010.02.013

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  15 in total

1.  A solid-phase assay for studying direct binding of progranulin to TNFR and progranulin antagonism of TNF/TNFR interactions.

Authors:  Qingyun Tian; Shuai Zhao; Chuanju Liu
Journal:  Methods Mol Biol       Date:  2014

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains.

Authors:  Jinlong Jian; Shuai Zhao; Qingyun Tian; Elena Gonzalez-Gugel; Jyoti Joshi Mundra; Sardar M Z Uddin; Ben Liu; Brendon Richbourgh; Ryan Brunetti; Chuan-ju Liu
Journal:  FEBS Lett       Date:  2013-09-23       Impact factor: 4.124

Review 4.  Structure, function, and mechanism of progranulin; the brain and beyond.

Authors:  Huishi Toh; Babykumari P Chitramuthu; Hugh P J Bennett; Andrew Bateman
Journal:  J Mol Neurosci       Date:  2011-06-21       Impact factor: 3.444

Review 5.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 6.  Progranulin: an emerging target for FTLD therapies.

Authors:  Jennifer Gass; Mercedes Prudencio; Caroline Stetler; Leonard Petrucelli
Journal:  Brain Res       Date:  2012-01-28       Impact factor: 3.252

Review 7.  Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration.

Authors:  Basar Cenik; Chantelle F Sephton; Bercin Kutluk Cenik; Joachim Herz; Gang Yu
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

Review 8.  The lysosomal function of progranulin, a guardian against neurodegeneration.

Authors:  Daniel H Paushter; Huan Du; Tuancheng Feng; Fenghua Hu
Journal:  Acta Neuropathol       Date:  2018-05-09       Impact factor: 17.088

9.  Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins.

Authors:  Sandra Almeida; Lijuan Zhou; Fen-Biao Gao
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

Review 10.  Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.

Authors:  Janis Bennion Callister; Stuart M Pickering-Brown
Journal:  Exp Neurol       Date:  2014-06-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.